chitosan and plga microspheres as drug delivery ... - UniCA Eprints

More documents

Recommendations

Info

9. References173. Zeng X.M., Martin G.P. and Marriott C. The preparation and in vitro evaluation of tetrandrineentrappedalbumin microspheres as an inhalation drug delivery system. Eur. J. Pharm. Sci. vol. 3p. 87-93, 1995.174. Tice T.R., Mason D.W. and Gilley R.M. Clinical use and future of parenteral microspheredelivery systems. In Prescott, L.F. and Nimmo, W.S. (Eds), Novel Drug Delivery and itsTherapeutic Application, Wiley, New York. p. 223-235, 1989.175. Masinde L. and Hickey A.J. Nebulization of poly(lactic acid) microspheres from aqueoussuspension. Pharm. Res. Vol. 8 p. 120, 1991.176. Lai Y.L., Mehta R.C., Thacker A.A., Yoo S.-D., McNamara P.J. and Deluca P.P. Sustainedbronchodilation with isoproterenol poly(glycolide-co-lactide) microspheres. Pharm. Res. Vol. 10,p. 119-125, 1993.177. Edwards D.A., Hanes J., Caponetti G., Hrkach J., Ben Jebria A., Eskew M.L., Mintzes J.,Deaver D., Lotan N., Langer R. Large porous particles for pulmonary drug delivery. Science. Vol.276, p. 1868-1871, 1997.178. O’Hara P., Hickey A.J. Respirable PLGA microspheres containing rifampicin for thetreatment of tuberculosis: Manufacture and characterization. Pharm Res. Vol. 17, p. 955-961,2000.179. O’Hara P. and Hickey A.J. Respirable PLGA Microspheres Containing Rifampicin for theTreatment of Tuberculosis: Manufacture and Characterization Pharmaceutical Research, Vol.17/8, 2000.180. Pandey R., Khuller G.K. Chemotherapeutic potential of alginate–chitosan microspheres asantitubercular drug carriers. J Antimicrob Chemother. vol. 53, p. 635-40, 2004.181. Tonnesen H.H., Karlsen J. Alginate in drug delivery systems. Drug Dev Ind Pharm. Vol. 28, p.621-30, 2002.182. Mukherjee J.S., Rich M.L., Socci A.R. et al.. Programmes and principles in treatment ofmultidrug-resistant tuberculosis. Lancet. Vol. 363, p. 474-81, 2004.183. Muzzarelli R.A.A. Chitin. Pergamon Press, New York. p. 1-37, 1977.184. Roberts G.A.F. Chitin Chemistry. Mac Millian Press, Houndmills. p. 1-50, 1992.185. Kas H.S. Chitosan: properties, preparation and application to microparticulate systems. J.Microencapsul. Vol. 14, p. 689-711, 1997.186. Singla A.K., Sharma M.L., Dhawan S. Nifedipine loaded chitosan microspheres:characterization of internal structure. Biotech. Histochem. Vol. 76, p. 165-171, 2001.187. Kato Y., Onishi H., Machida Y. Application of chitin and chitosan derivatives in thepharmaceutical field. Curr. Pharm. Biotechnol. Vol. 4, p. 303-309, 2003.188. Fukuda H. Polyelectrolyte complexes of chitosan carboxymethyl cellulose. Bull. Chem. Soc.Jpn. Vol. 53, p. 837-840, 1980.189. Chandy T., Sharma C.P. Chitosan as a biomaterial biomater. Artif. Cells Artif. Organs. Vol.18, p. 1-24, 1990.190. Illum L., Jabbal-Gill I., Hinchcliffe M., Fisher A.N., Davis S.S. Chitosan as a novel nasaldelivery system for vaccines. Adv. Drug Deliv. Rev. vol. 51, p. 81-96, 2001.191. Furda I. Nonabsorbable lipid binder. US Patent 4,223,023, 1980.192. Nagyuvary J.J. Treating hyperbilirubinemia. US Patent 4,363,801, 1982.193. Tachihara K., Onishi H., Machida Y. Preparation of silver sulfadiazine-containing spongymembranes of chitosan and chitin–chitosan mixture and their evaluation as burn wound dressings.Arch. Practical Pharm. Vol. 57, p. 159-167, 1997.194. Felt O., Furrer P., Mayer J.M., Plazonnet B., Buri P., Gurny R. Topical use of chitosan inophthalmology: tolerance assessment and evaluation of precorneal retention. Int. J. Pharm. Vol.180, p. 185-193, 1999.195. Kristmundsdottir T., Ingvarsdottir K., Saemundsdottir G. Chitosan matrix tablets: theinfluence of excipients on drug release. Drug Dev. Ind. Pharm. Vol. 21, p. 1591-1598, 1995.196. Sabnis S., Rege P., Block L.H. Use of chitosan in compressed tablets of diclofenac sodium:inhibition of drug release in an acidic environment. Pharm. Dev. Technol. vol. 2, p. 243-255,1997.130
9. References197. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. Vol. 15, p. 1326-1331, 1998.198. Upadrashta S.M., Katikaneni P.R., Nuessle N.O. Chitosan as a tablet binder. Drug Dev. Ind.Pharm. Vol. 18, p. 1701-1708, 1992.199. Ilango R., Kavimani S., Premila J., Nair D.K., Jayakar B. Studies on tablets ofsulphamethoxazole using chitosan. Ind. J. Pharm. Sci. vol. 59, p. 220-224, 1997.200. Hou W.M., Miyazaki S., Takada M., Komai T. Sustained release of indomethacin fromchitosan granules. Chem. Pharm. Bull. Vol. 33, p. 3986–3992, 1985.201. Kawashima Y., Handa T., Kasai A., Takenaka H., Lin S.Y. The effects of thickness andhardness of the coating film on the drug release rate of theophylline granules coated withchitosan–sodium tripolyphosphate complex. Chem. Pharm. Bull. Vol. 33, p. 2469-2474, 1985a.202. Miyazaki T., Komuro T., Yomota C., Okada S. Use of chitosan as a pharmaceutical materialeffectiveness as an additional additive of sodium alginate. Eisei Shikenjo Hokoku. Vol. 108, 95-97, 1990.203. Akbuga J. Effect of the physicochemical properties of a drug on its release from chitosanmalate matrix tablets. Int. J. Pharm. Vol. 100, p. 257-261, 1993.204. Kristl J., Smidx-Korbar J., Struc E., Schara M., Rupprecht H. Hydrocolloids and gels ofchitosan as drug carriers. Int. J. Pharm. Vol. 99, p. 13-19, 1993.205. Miyazaki S., Ishii K., Nadai T. Use of chitin and chitosan as drug carriers. Chem. Pharm. Bull.Vol. 29, p. 3067-3069, 1981.206. Sawayanagi Y., Nambu N., Nagai T. Enhancement of dissolution properties of griseofulvinfrom ground mixtures with chitin and chitosan. Chem. Pharm. Bull. Vol. 30, p. 4464-4467, 1982a.207. Shiraishi S., Arahira M., Imai T., Otagiri M. Enhancement of dissolution rates of several drugsby low-molecular weight chitosan and alginate. Chem. Pharm. Bull. Vol.38, p. 185-187, 1990.208. Lehr C.M., Bouwstra J.A., Schacht E.H., Junginger H.E. In vitro evaluation of mucoadhesiveproperties of chitosan and some other natural polymers. Int. J. Pharm. Vol. 78, p. 43-48, 1992.209. He P., Davis S.S., Illum L. In vitro evaluation of the mucoadhesive properties of chitosanmicrospheres. Int. J. Pharm. Vol 166, p. 75-88, 1998.210. Kockisch S., Rees G.D., Young S.A., Tsibouklis J., Smart J.D. Polymeric microspheres fordrug delivery to the oral cavity: an in vitro evaluation of mucoadhesive potential. J. Pharm. Sci.vol. 92, p. 1614-1623, 2003.211. Schipper N.G.M., Olsson S., Hoogstraate J.A., de Boer A.G., Varum K.M., Artursson P.Chitosans as absorption enhancers for poorly absorbable drugs. 2: Mechanism of absorptionenhancement. Pharm. Res. Vol. 14, p. 923-929, 1997.212. Dodane V., Khan M.A., Merwin J.R. Effect of chitosan on epithelial permeability andstructure. Int. J. Pharm. Vol. 182, p. 21-32, 1999.213. Schipper N.G.M., Varum K.M., Artursson P. Chitosan as absorption enhancers for poorlyabsorbable drugs. 1: Influence of molecular weight and degree of acetylation on drug transportacross human epithelial (Caco-2) cells. Pharm. Res. Vol. 13, p. 1686-1692, 1996.214. Lueen H.L., Lehr C.M., Rentel C.O., Noach A.B.J., de Boer A.G., Verhoef J.C., JungingerH.E. Bioadhesive polymers for the peroral delivery of peptide drugs. J. Control Rel. vol. 29, p.329-338, 1994.215. Soane R.J., Frier M., Perkins A.C., Jones N.S., Davis S.S., Illum L. Evaluation of theclearance characteristics of bioadhesive systems in humans. Int. J. Pharm. Vol. 178, p. 55-65,1999.216. Gallo J.M., Hassan E.E. Receptor-mediated magnetic carriers: basis for targeting. Pharm. Res.Vol. 5, p. 300-304, 1988.217. Orienti I., Aiedeh K., Gianasi E., Bertasi V., Zecchi V. Indomethacin loaded chitosanmicrospheres. Correlation between the erosion process and release kinetics. J. Microencapsul. Vol.13, p. 463-472, 1996.218. Nishioka Y., Kyotani S., Okamura M., Miyazaki M., Okazaki K., Ohnishi S., Yamamoto Y.,Ito K. Release characteristics of cisplatin chitosan microspheres and effect of containing chitin.Chem. Pharm. Bull. Vol. 38, p. 2871-2873, 1990.131
Page 1:
European Union Ministero dell’Uni
Page 5 and 6:
Table Of Contents1. GENERAL INTRODU
Page 7:
7.1.4. Release Studies/Stability St
Page 10 and 11:
1. General Introduction1.1. Pulmona
Page 12 and 13:
1. General Introductionmucosa, and
Page 14 and 15:
1. General Introductionis the fact
Page 16 and 17:
1.3. Lung Anatomy1. General Introdu
Page 18 and 19:
1. General Introductionhighly vascu
Page 20 and 21:
201. General Introductionliquid (84
Page 22 and 23:
1. General IntroductionAerosol size
Page 24 and 25:
1. General Introductionof numerous
Page 26 and 27:
1. General Introductionintermittent
Page 28 and 29:
1. General Introductionsphere prepa
Page 30 and 31:
1. General Introductionit, respecti
Page 32 and 33:
1. General Introductionthe subject
Page 34 and 35:
1. General IntroductionA. zahoor et
Page 36 and 37:
2. Chitosan And PLGA2.1. Chitosan a
Page 38 and 39:
2. Chitosan And PLGAfor the prepara
Page 40 and 41:
2. Chitosan And PLGAmainly controll
Page 42 and 43:
2. Chitosan And PLGAAt present, a n
Page 44 and 45:
2. Chitosan And PLGAneed to be a go
Page 46 and 47:
2. Chitosan And PLGAdichloromethane
Page 49 and 50:
3. Aim of the Work49
Page 51:
3. Aim of the WorkBiodegradable mic
Page 54 and 55:
4. RFP Loaded Chitosan Microspheres
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 71 and 72:
5. Rifampicin Loaded ChitosanMicros
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80: 5. RFP Loaded Chitosan Microspheres
Page 81 and 82: 5. RFP Loaded Chitosan Microspheres
Page 83: 5. RFP Loaded Chitosan Microspheres
Page 86 and 87: 6. RFP Loaded PLGA Microspheres Pre
Page 100 and 101: 100
Page 102 and 103: 7. RFP Loaded PLGA Coated Chitosan
Page 118 and 119: 118
Page 120 and 121: 8. Final Discussion and Conclusions
Page 122 and 123: 9. References9. References1. Fred S
Page 124 and 125: 9. References40. Wayne L.G., Good R
Page 126 and 127: 1269. References88. Carpenter R.L.
Page 128 and 129: 1289. References135. Fukushima S.;
Page 132 and 133: 9. References219. Berthold A., Crem
Page 134: 9. Referencesmediates target gene e
show all

chitosan and plga microspheres as drug delivery ... - UniCA Eprints

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?